Search This Blog

Monday, July 29, 2019

Neurocrine Biosciences EPS beats by $0.32, beats on revenue

Neurocrine Biosciences (NASDAQ:NBIX): Q2 GAAP EPS of $0.54 beats by $0.32.
Revenue of $183.58M (+89.4% Y/Y) beats by $21.79M.
Shares +9.23%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)